FAQs
What are ROVI's activities in the pharmaceutical market at present?
In which pharmaceutical areas is ROVI present?
What are the main factors in ROVI’s strategy?
News
11/05/2022
First quarter 2022 results press release
ROVI REPORTS OPERATING REVENUE GROWTH OF 57% AND NET PROFIT GROWTH OF 123%
8/04/2022
Recall Notification of Lot #000190A
Madrid – 08 April, 2022 - Moderna and ROVI Pharma Industrial Services, S.A.U. today announced a recall of one lot (lot #000190A) of the Moderna COVID-19 vaccine (Spikevax®).
4/03/2022
ROVI WAS CARBON NEUTRAL IN 2021
Madrid, 4 de marzo de 2022 - Laboratorios Farmacéuticos Rovi, S.A. was certified carbon neutral in 2021 for the second year running.
Contact
At ROVI, we have a policy of transparency and direct communication. Therefore, you may contact us directly whenever you need to do so.
ROVI
Head Offices
Julián Camarillo 35
28037 Madrid - Spain
28037 Madrid - Spain
Tel +(34) 91 375 62 30
Fax +(34) 91 375 62 30
Email: rovi@rovi.es